![](/img/cover-not-exists.png)
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design
Cascione, Mark, Wynn, Daniel, Barbato, Luigi M., Pestreich, Linda, Schofield, Lesley, McCague, KevinVolume:
16
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2013.802239
Date:
July, 2013
File:
PDF, 188 KB
english, 2013